FLAG-mitoxantrone combined with low-dose venetoclax (7 Days): A highly efficient regimen and excellent bridge for allogeneic hematopoietic transplant for newly diagnosed and relapsed/refractory AML.
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Ahmad Ibrahim, Kamal Al Zahran, Ahmad Khalil, Ali Youssef, Jad Ibrahim, Mohamad Abbas, Charbel Khalil, Rima Moghnieh, Joseph Makdessi
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417008988
Cites:
Cited by:
Related to: